Evidence map›Paper›PMID 37761814›Full record

ArticleGenes2023

Glutathione Peroxidase

Cristina Cueto-Ureña, María Jesús Ramírez-Expósito, María Dolores Mayas, María Pilar Carrera-González, Alicia Godoy-Hurtado, José Manuel Martínez-Martos

Open access · goldAbstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Advances in the role of GPX3 in ovarian cancer (Review).International journal of oncology · 2024
    Article
  6. Article
  7. In Vitro Antioxidant and Inhibitory Study ofDose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cristina Cueto-UreñaExperimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Experimental and Health Sciences, University of Jaén, 23071 Jaén, Spain.
María Jesús Ramírez-ExpósitoExperimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Experimental and Health Sciences, University of Jaén, 23071 Jaén, Spain.ORCID 0000-0002-9379-203X
María Dolores MayasExperimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Experimental and Health Sciences, University of Jaén, 23071 Jaén, Spain.
María Pilar Carrera-GonzálezExperimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Experimental and Health Sciences, University of Jaén, 23071 Jaén, Spain.ORCID 0000-0001-6575-8240
Alicia Godoy-HurtadoDepartment of Neurosurgery, Jaén Neurotrauma Hospital, 23009 Jaén, Spain.ORCID 0000-0003-0579-4463
José Manuel Martínez-MartosExperimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Experimental and Health Sciences, University of Jaén, 23071 Jaén, Spain.ORCID 0000-0002-2950-5614
Universidad de Jaén · ESComplejo Hospitalario de Jaén · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensive research efforts in the field of brain tumor studies have led to the reclassification of tumors by the World Health Organization (WHO) and the identification of various molecular subtypes, aimed at enhancing diagnosis and treatment strategies. However, the quest for biomarkers that can provide a deeper understanding of tumor development mechanisms, particularly in the case of gliomas, remains imperative due to their persistently incurable nature. Oxidative stress has been widely recognized as a key mechanism contributing to the formation and progression of malignant tumors, with imbalances in antioxidant defense systems being one of the underlying causes for the excess production of reactive oxygen species (ROS) implicated in tumor initiation. In this study, we investigated the gene expression patterns of the eight known isoforms of glutathione peroxidase (GPx) in brain tissue obtained from male and female control rats, as well as rats with transplacental ethyl nitrosourea (ENU)-induced brain tumors. Employing the delta-delta Ct method for RT-PCR, we observed minimal expression levels of

Indexed as

Brain NeoplasmsGliomaGlutathione PeroxidaseAnimalsBrainFemaleGlutathione Peroxidase GPX1MalePhospholipid Hydroperoxide Glutathione PeroxidaseRatsGlutathione Peroxidaseglutathione peroxidase 2, ratglutathione peroxidase 4, ratGlutathione Peroxidase GPX1GPX3 protein, ratGpx6 protein, ratGpx7 protein, ratGpx8 protein, ratPhospholipid Hydroperoxide Glutathione Peroxidaseselenium-independent glutathione peroxidasebrain tumorsfree radicalsgenderglutathione peroxidasesoxidative stressWistar

Identifiers

PMID37761814
PMCPMC10530768
OpenAlexW4386119608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.